• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于电子健康档案的 NAFLD 研究中的行政编码:专家小组共识声明。

Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement.

机构信息

Division of Hepatology, Department of Upper GI, Karolinska University Hospital, Stockholm, Sweden.

Clinical Epidemiology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.

出版信息

Hepatology. 2021 Jul;74(1):474-482. doi: 10.1002/hep.31726. Epub 2021 Jun 22.

DOI:10.1002/hep.31726
PMID:33486773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8515502/
Abstract

BACKGROUND AND AIMS

Electronic health record (EHR)-based research allows the capture of large amounts of data, which is necessary in NAFLD, where the risk of clinical liver outcomes is generally low. The lack of consensus on which International Classification of Diseases (ICD) codes should be used as exposures and outcomes limits comparability and generalizability of results across studies. We aimed to establish consensus among a panel of experts on ICD codes that could become the reference standard and provide guidance around common methodological issues.

APPROACH AND RESULTS

Researchers with an interest in EHR-based NAFLD research were invited to collectively define which administrative codes are most appropriate for documenting exposures and outcomes. We used a modified Delphi approach to reach consensus on several commonly encountered methodological challenges in the field. After two rounds of revision, a high level of agreement (>67%) was reached on all items considered. Full consensus was achieved on a comprehensive list of administrative codes to be considered for inclusion and exclusion criteria in defining exposures and outcomes in EHR-based NAFLD research. We also provide suggestions on how to approach commonly encountered methodological issues and identify areas for future research.

CONCLUSIONS

This expert panel consensus statement can help harmonize and improve generalizability of EHR-based NAFLD research.

摘要

背景与目的

电子健康记录(EHR)为研究提供了大量数据,这在非酒精性脂肪性肝病(NAFLD)的研究中非常重要,因为 NAFLD 的临床肝脏结局风险通常较低。缺乏共识,导致哪些国际疾病分类(ICD)代码应作为暴露和结局使用,限制了研究间结果的可比性和普遍性。我们旨在通过专家小组就可作为参考标准的 ICD 代码达成共识,并就常见的方法学问题提供指导。

方法与结果

我们邀请对 EHR 为基础的 NAFLD 研究有兴趣的研究人员共同定义哪些行政代码最适合记录暴露和结局。我们使用改良 Delphi 方法就该领域中常见的几个方法学挑战达成共识。经过两轮修订,所有被认为相关的项目都达成了>67%的高度一致性。最终达成了共识,确定了一个综合的行政代码列表,用于定义 EHR 为基础的 NAFLD 研究中的纳入和排除标准。我们还就如何处理常见的方法学问题以及确定未来研究领域提出了建议。

结论

该专家小组的共识声明有助于协调和提高 EHR 为基础的 NAFLD 研究的普遍性。

相似文献

1
Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement.基于电子健康档案的 NAFLD 研究中的行政编码:专家小组共识声明。
Hepatology. 2021 Jul;74(1):474-482. doi: 10.1002/hep.31726. Epub 2021 Jun 22.
2
Identifying clinical features in primary care electronic health record studies: methods for codelist development.在基层医疗电子健康记录研究中识别临床特征:代码列表开发方法
BMJ Open. 2017 Nov 22;7(11):e019637. doi: 10.1136/bmjopen-2017-019637.
3
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group.非酒精性脂肪性肝病(NAFLD)管理的质量标准:英国肝脏研究协会和英国胃肠病学会NAFLD特别兴趣小组的共识建议
Lancet Gastroenterol Hepatol. 2022 Aug;7(8):755-769. doi: 10.1016/S2468-1253(22)00061-9. Epub 2022 Apr 28.
4
Capturing pharmacists' impact in general practice: an e-Delphi study to attempt to reach consensus amongst experts about what activities to record.捕捉药剂师在全科医疗中的影响:一项电子德尔菲研究,旨在尝试在专家中达成共识,确定应记录哪些活动。
BMC Fam Pract. 2019 Sep 9;20(1):126. doi: 10.1186/s12875-019-1008-6.
5
Assessing the Precision of ICD-10 Codes for Uveitis in 2 Electronic Health Record Systems.评估 2 个电子健康记录系统中葡萄膜炎 ICD-10 编码的精度。
JAMA Ophthalmol. 2018 Oct 1;136(10):1186-1190. doi: 10.1001/jamaophthalmol.2018.3001.
6
Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM.在健康数据库中检测非酒精性脂肪性肝病及相关危险因素:ICD-10-AM 的准确性和局限性。
BMJ Open Gastroenterol. 2021 Feb;8(1). doi: 10.1136/bmjgast-2020-000572.
7
Advancing the global public health agenda for NAFLD: a consensus statement.推进非酒精性脂肪性肝病的全球公共卫生议程:共识声明。
Nat Rev Gastroenterol Hepatol. 2022 Jan;19(1):60-78. doi: 10.1038/s41575-021-00523-4. Epub 2021 Oct 27.
8
Using Clinical Vignettes and a Modified Expert Delphi Panel to Determine Parameters for Identifying Non-Traumatic Spinal Cord Injury in Health Administrative and Electronic Medical Record Databases.利用临床案例和改良的专家德尔菲小组确定健康管理和电子病历数据库中识别非创伤性脊髓损伤的参数。
Arch Phys Med Rehabil. 2023 Jan;104(1):63-73. doi: 10.1016/j.apmr.2022.08.002. Epub 2022 Aug 21.
9
Defining ICD-10 surrogate variables to estimate the modified frailty index: a Delphi-based approach.定义 ICD-10 替代变量来估计改良的衰弱指数:基于德尔菲法的方法。
BMC Geriatr. 2022 May 13;22(1):422. doi: 10.1186/s12877-022-03063-x.
10
Users' perspectives of key factors to implementing electronic health records in Canada: a Delphi study.用户对加拿大实施电子健康记录的关键因素的看法:一项德尔菲研究。
BMC Med Inform Decis Mak. 2012 Sep 11;12:105. doi: 10.1186/1472-6947-12-105.

引用本文的文献

1
Associations of child-to-adult body size change with risk of hypertension and metabolic dysfunction-associated steatotic liver disease: a population-based cohort study of 226,420 individuals.儿童至成人体型变化与高血压及代谢功能障碍相关脂肪性肝病风险的关联:一项基于人群的队列研究,涉及226,420名个体。
BMC Public Health. 2025 Sep 2;25(1):3008. doi: 10.1186/s12889-025-24317-4.
2
Low-density lipoprotein cholesterol and clinical outcomes in patients with liver cirrhosis: a nationwide cohort study.肝硬化患者的低密度脂蛋白胆固醇与临床结局:一项全国性队列研究。
Ann Med. 2025 Dec;57(1):2551813. doi: 10.1080/07853890.2025.2551813. Epub 2025 Aug 30.
3
EAT-Lancet diet and risk of metabolic dysfunction-associated steatotic liver disease and other liver chronic diseases: a large prospective cohort study in the UK Biobank.饮食与生活方式医学委员会(EAT)-柳叶刀委员会饮食与代谢功能障碍相关脂肪性肝病及其他肝脏慢性疾病风险:英国生物银行的一项大型前瞻性队列研究
Front Nutr. 2025 Jul 31;12:1589424. doi: 10.3389/fnut.2025.1589424. eCollection 2025.
4
Adding salt to foods increases the risk of metabolic dysfunction-associated steatotic liver disease.在食物中加盐会增加代谢功能障碍相关脂肪性肝病的风险。
Commun Med (Lond). 2025 Aug 8;5(1):342. doi: 10.1038/s43856-025-01074-4.
5
Associations between an inflammatory diet index and nonunion: a prospective study of 172,839 UK biobank participants.炎症饮食指数与骨不连之间的关联:对172,839名英国生物银行参与者的前瞻性研究。
Front Nutr. 2025 Jul 14;12:1640259. doi: 10.3389/fnut.2025.1640259. eCollection 2025.
6
Dietary quercetin intake is not associated with risk of metabolic dysfunction-associated steatotic liver disease in a general adult population.在普通成年人群中,膳食槲皮素摄入量与代谢功能障碍相关脂肪性肝病的风险无关。
Eur J Nutr. 2025 Jul 22;64(5):246. doi: 10.1007/s00394-025-03764-0.
7
Association of estimated glucose disposal rate with risk of future metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases: a prospective cohort study.估计葡萄糖处置率与未来代谢功能障碍相关脂肪性肝病及其他慢性肝病风险的关联:一项前瞻性队列研究
Front Med (Lausanne). 2025 Jul 2;12:1589245. doi: 10.3389/fmed.2025.1589245. eCollection 2025.
8
Adverse pregnancy and birth outcomes in women with biopsy-proven MASLD: a nationwide cohort study.经活检证实的代谢功能障碍相关脂肪性肝病(MASLD)女性的不良妊娠和分娩结局:一项全国性队列研究。
EClinicalMedicine. 2025 May 9;83:103238. doi: 10.1016/j.eclinm.2025.103238. eCollection 2025 May.
9
Risk of pancreatic cancer according to glycemic status in nonalcoholic fatty liver disease: a nationwide cohort study.非酒精性脂肪性肝病患者血糖状态与胰腺癌风险:一项全国性队列研究
Sci Rep. 2025 Jul 2;15(1):23308. doi: 10.1038/s41598-025-05868-3.
10
Association of GLP1-Receptor Agonists with Risk of Hepatocellular Carcinoma: A Retrospective Cohort Study.胰高血糖素样肽-1受体激动剂与肝细胞癌风险的关联:一项回顾性队列研究。
Drug Saf. 2025 Jun 30. doi: 10.1007/s40264-025-01558-1.

本文引用的文献

1
Validity of administrative codes associated with cirrhosis in Sweden.瑞典与肝硬化相关的行政编码的有效性。
Scand J Gastroenterol. 2020 Oct;55(10):1205-1210. doi: 10.1080/00365521.2020.1820566. Epub 2020 Sep 22.
2
Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease.非酒精性脂肪性肝病增加了发生慢性肾脏病的风险。
United European Gastroenterol J. 2020 Oct;8(8):942-948. doi: 10.1177/2050640620944098. Epub 2020 Jul 23.
3
Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions.饮酒与肥胖:酒精性肝病/非酒精性脂肪性肝病的相互作用。
Semin Liver Dis. 2020 May;40(2):154-162. doi: 10.1055/s-0040-1701443. Epub 2020 Feb 18.
4
Identifying Patients With Hepatic Encephalopathy Using Administrative Data in the ICD-10 Era.在 ICD-10 时代,利用行政数据识别肝性脑病患者。
Clin Gastroenterol Hepatol. 2021 Mar;19(3):604-606.e1. doi: 10.1016/j.cgh.2019.12.017. Epub 2019 Dec 27.
5
Patatin-Like Phospholipase Domain-Containing Protein 3 I148M and Liver Fat and Fibrosis Scores Predict Liver Disease Mortality in the U.S. Population.载脂蛋白样磷酯酶结构域蛋白 3 I148M 与肝脂肪及纤维化评分预测美国人群的肝脏疾病死亡率。
Hepatology. 2020 Mar;71(3):820-834. doi: 10.1002/hep.31032. Epub 2020 Mar 5.
6
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults.非酒精性脂肪性肝病与急性心肌梗死和卒中发病风险的关系:来自 1800 万欧洲成年人匹配队列研究的结果。
BMJ. 2019 Oct 8;367:l5367. doi: 10.1136/bmj.l5367.
7
Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease.无创评分系统识别人群中发生严重肝脏疾病风险的能力。
Gastroenterology. 2020 Jan;158(1):200-214. doi: 10.1053/j.gastro.2019.09.008. Epub 2019 Sep 26.
8
Risks of Light and Moderate Alcohol Use in Fatty Liver Disease: Follow-Up of Population Cohorts.在脂肪肝疾病中,轻度和中度饮酒的风险:人群队列的随访。
Hepatology. 2020 Mar;71(3):835-848. doi: 10.1002/hep.30864. Epub 2019 Oct 8.
9
Validation of an algorithm using inpatient electronic health records to determine the presence and severity of cirrhosis in patients with hepatocellular carcinoma in England: an observational study.利用英格兰住院电子健康记录验证算法,以确定肝细胞癌患者中肝硬化的存在和严重程度:一项观察性研究。
BMJ Open. 2019 Jul 9;9(7):e028571. doi: 10.1136/bmjopen-2018-028571.
10
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts.在四个欧洲队列中对诊断为非酒精性脂肪性肝病的成年人进行的真实世界研究:肝硬化和肝细胞癌诊断的风险和临床预测因子。
BMC Med. 2019 May 20;17(1):95. doi: 10.1186/s12916-019-1321-x.